Richard A. Young - 17 Mar 2023 Form 4 Insider Report for Omega Therapeutics, Inc. (OMGAQ)

Role
Director
Signature
/s/ Barbara Chan as Attorney-in-Fact for Richard A. Young, Ph.D.
Issuer symbol
OMGAQ
Transactions as of
17 Mar 2023
Net transactions value
-$80,000
Form type
4
Filing time
20 Mar 2023, 16:05:15 UTC
Previous filing
11 Jan 2023
Next filing
10 Apr 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OMGA Common Stock Sale $80,000 -10,000 -1.3% $8.00 754,118 17 Mar 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 31, 2022.